The neuroscience of drug reward and addiction

ND Volkow, M Michaelides, R Baler - Physiological reviews, 2019 - journals.physiology.org
Drug consumption is driven by a drug's pharmacological effects, which are experienced as
rewarding, and is influenced by genetic, developmental, and psychosocial factors that …

Dopamine in health and disease: much more than a neurotransmitter

R Franco, I Reyes-Resina, G Navarro - Biomedicines, 2021 - mdpi.com
Dopamine is derived from an amino acid, phenylalanine, which must be obtained through
the diet. Dopamine, known primarily to be a neurotransmitter involved in almost any higher …

Sex differences in dopamine receptors and relevance to neuropsychiatric disorders

OOF Williams, M Coppolino, SR George, ML Perreault - Brain sciences, 2021 - mdpi.com
Dopamine is an important neurotransmitter that plays a key role in neuropsychiatric illness.
Sex differences in dopaminergic signaling have been acknowledged for decades and have …

The signaling and pharmacology of the dopamine D1 receptor

J Jones-Tabah, H Mohammad, EG Paulus… - Frontiers in Cellular …, 2022 - frontiersin.org
The dopamine D1 receptor (D1R) is a Gαs/olf-coupled GPCR that is expressed in the
midbrain and forebrain, regulating motor behavior, reward, motivational states, and cognitive …

Sex difference in dopamine D1-D2 receptor complex expression and signaling affects depression-and anxiety-like behaviors

A Hasbi, T Nguyen, H Rahal, JD Manduca… - Biology of sex …, 2020 - Springer
Depression and anxiety are more common among females than males and represent a
leading cause of disease-related disability in women. Since the dopamine D1-D2 heteromer …

Dopamine receptors: is it possible to become a therapeutic target for depression?

F Zhao, Z Cheng, J Piao, R Cui, B Li - Frontiers in Pharmacology, 2022 - frontiersin.org
Dopamine and its receptors are currently recognized targets for the treatment of several
neuropsychiatric disorders, including Parkinson's disease, schizophrenia, some drug use …

2016 Philip S. Portoghese medicinal chemistry lectureship: designing bivalent or bitopic molecules for G-protein coupled receptors. The whole is greater than the sum …

AH Newman, FO Battiti, A Bonifazi - Journal of medicinal chemistry, 2019 - ACS Publications
The genesis of designing bivalent or bitopic molecules that engender unique
pharmacological properties began with Portoghese's work directed toward opioid receptors …

Mapping the Interface of a GPCR Dimer: A Structural Model of the A2A Adenosine and D2 Dopamine Receptor Heteromer

DO Borroto-Escuela, D Rodriguez… - Frontiers in …, 2018 - frontiersin.org
The A2A adenosine (A2AR) and D2 dopamine (D2R) receptors form oligomers in the cell
membrane and allosteric interactions across the A2AR–D2R heteromer represent a target …

[HTML][HTML] Dopamine D1-D2 receptor heteromer expression in key brain regions of rat and higher species: Upregulation in rat striatum after cocaine administration

A Hasbi, M Sivasubramanian, M Milenkovic… - Neurobiology of …, 2020 - Elsevier
Background Dopamine receptors interact with other receptors to form heterooligomers. One
such complex, the D1-D2 heteromer, demonstrated in cultured striatal neurons and rat …

Dopamine D1 and D2 receptors differentially regulate Rac1 and Cdc42 signaling in the nucleus accumbens to modulate behavioral and structural plasticity after …

G Tu, L Ying, L Ye, J Zhao, N Liu, J Li, Y Liu, M Zhu… - Biological …, 2019 - Elsevier
Background Methamphetamine (METH) is a highly addictive psychostimulant that strongly
activates dopamine receptor signaling in the nucleus accumbens (NAc). However, how …